{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:50:58Z","timestamp":1753890658897,"version":"3.41.2"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Spontaneous coronary artery dissection (SCAD) is a rare coronary artery disease that frequently occurs in young, female patients without risk factors, and conservative treatment is often recommended for its management. The patient reported here is a male patient with systemic lupus erythematosus (SLE).<\/jats:p><\/jats:sec><jats:sec><jats:title>Case summary<\/jats:title><jats:p>We described a 28-year-old man with SLE who presented with acute ST-segment elevation myocardial infarction (STEMI), and was diagnosed with SCAD through a long dissection of the left anterior descending branch (LAD) by coronary angiography. The patient was treated with percutaneous coronary intervention (PCI) with stent implantation. Ten years later, he developed in-stent stenosis and other coronary atherosclerosis and was retreated with PCIs. Based on this case and according to the literature review, the existing treatment and prognosis of SLE with spontaneous coronary artery dissection and atherosclerosis are discussed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Cardiovascular complications should be considered in patients with systemic lupus erythematosus, although they may not initially be atherosclerotic diseases. Attention should be paid to distinguish spontaneous coronary dissection in order to minimize missed or delayed diagnoses and take appropriate managements, as well as the development of atherosclerosis in SLE patients, and timely intervention has a better prognosis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.951188","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T07:13:59Z","timestamp":1660115639000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Spontaneous coronary artery dissection and atherosclerosis in a young man with systemic lupus erythematosus: A case report and literature review"],"prefix":"10.3389","volume":"9","author":[{"given":"Hongbo","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dazhuo","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuhai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3978\/j.issn.2223-3652.2015.01.08","article-title":"Spontaneous coronary artery dissection-A review","volume":"5","author":"Yip","year":"2015","journal-title":"Cardiovasc Diagn Ther."},{"key":"B2","first-page":"92","article-title":"Spontaneous healing of spontaneous coronary artery dissection","volume":"17","author":"Almafragi","year":"2010","journal-title":"Cardiol J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1093\/eurheartj\/ehy080","article-title":"Writing Committee. European Society of Cardiology, acute cardiovascular care association, SCAD study group: a position paper on spontaneous coronary artery dissection","volume":"39","author":"Adlam","year":"2018","journal-title":"Eur Heart J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11883-020-00866-4","article-title":"Spontaneous coronary artery dissection: latest developments and new frontiers","volume":"22","author":"Yang","year":"2020","journal-title":"Curr Atheroscler Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019 update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrrheum.2011.75","article-title":"Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE","volume":"7","author":"Symmons","year":"2011","journal-title":"Nat Rev Rheumatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1161\/CIRCULATIONAHA.112.105718","article-title":"Clinical features, management, and prognosis of spontaneous coronary artery dissection","volume":"126","author":"Tweet","year":"2012","journal-title":"Circulation."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/eurheartj\/ehz007","article-title":"Canadian spontaneous coronary artery dissection cohort study: in-hospital and 30-day outcomes","volume":"40","author":"Saw","year":"2019","journal-title":"Eur Heart J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e523","DOI":"10.1161\/CIR.0000000000000564","article-title":"Spontaneous coronary artery dissection: current state of the science: a scientific statement from the American Heart Association","volume":"137","author":"Hayes","year":"2018","journal-title":"Circulation."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e239","DOI":"10.1016\/j.jemermed.2012.07.042","article-title":"Spontaneous coronary artery dissection in a 27-year-old woman","volume":"44","author":"Besinger","year":"2013","journal-title":"J Emerg Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1056\/NEJMra2001524","article-title":"Spontaneous coronary-artery dissection","volume":"383","author":"Kim","year":"2020","journal-title":"N Engl J Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1007\/s00296-019-04351-3","article-title":"Spontaneous coronary artery dissection in systemic lupus erythematosus: case-based review","volume":"39","author":"\u00c1lvarez-Lario","year":"2019","journal-title":"Rheumatol Int."},{"key":"B13","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.jvs.2010.10.066","article-title":"Diagnosis, management, and future developments of fibromuscular dysplasia","volume":"53","author":"Olin","year":"2011","journal-title":"J Vasc Surg"},{"key":"B14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.mehy.2018.09.039","article-title":"Eosinophilic inflammation in spontaneous coronary artery dissection: a potential therapeutic target?","volume":"121","author":"Pitliya","year":"2018","journal-title":"Med Hypotheses."},{"key":"B15","doi-asserted-by":"publisher","first-page":"395.e7","DOI":"10.1016\/j.cjca.2015.06.021","article-title":"Corticosteroids and spontaneous coronary artery dissection: a new predisposing factor?","volume":"32","author":"Keir","year":"2016","journal-title":"Can J Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.amjcard.2018.10.012","article-title":"Conditions and factors associated with spontaneous coronary artery dissection (from a National Population-Based Cohort Study)","volume":"123","author":"Krittanawong","year":"2019","journal-title":"Am J Cardiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s12016-017-8640-5","article-title":"Unmet Needs in the pathogenesis and treatment of systemic lupus erythematosus","volume":"55","author":"Bakshi","year":"2018","journal-title":"Clin Rev Allergy Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.autrev.2015.10.002","article-title":"Subclinical atherosclerosis in patients with systemic lupus erythematosus: a systemic review and meta-analysis","volume":"15","author":"Wu","year":"2016","journal-title":"Autoimmun Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1136\/ard.2006.054973","article-title":"High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors","volume":"66","author":"Chung","year":"2007","journal-title":"Ann Rheum Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2017.05.008","article-title":"Cardiovascular disease in systemic lupus erythematosus: a comprehensive update","volume":"82","author":"Giannelou","year":"2017","journal-title":"J Autoimmun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41569-021-00541-4","article-title":"Global epidemiology of dyslipidaemias","volume":"18","author":"Pirillo","year":"2021","journal-title":"Nat Rev Cardiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1177\/09612033211006790","article-title":"Prevalence and treatment conditions for hypertension and dyslipidaemia complicated with systemic lupus erythematosus: a multi-centre cross-sectional study","volume":"30","author":"Saito","year":"2021","journal-title":"Lupus."},{"key":"B23","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s12026-016-8892-9","article-title":"Dyslipidemia in systemic lupus erythematosus","volume":"65","author":"Szab\u00f3","year":"2017","journal-title":"Immunol Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1136\/annrheumdis-2012-202914","article-title":"Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus","volume":"73","author":"Ronda","year":"2014","journal-title":"Ann Rheum Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1172\/JCI118345","article-title":"Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures","volume":"96","author":"Van Lenten","year":"1995","journal-title":"J Clin Invest."},{"key":"B26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s11926-009-0036-y","article-title":"Effects of inflammation on cholesterol metabolism: impact on systemic lupus erythematosus","volume":"11","author":"Reiss","year":"2009","journal-title":"Curr Rheumatol Rep."},{"key":"B27","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/joim.12357","article-title":"Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention","volume":"278","author":"Wigren","year":"2015","journal-title":"J Intern Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1161\/ATVBAHA.121.315928","article-title":"Anti-dsDNA antibodies increase the cardiovascular risk in systemic lupus erythematosus promoting a distinctive immune and vascular activation","volume":"41","author":"Pati\u00f1o-Trives","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.autrev.2015.03.002","article-title":"Neutrophil extracellular traps and their role in the development of chronic inflammation and autoimmunity","volume":"14","author":"Pinegin","year":"2015","journal-title":"Autoimmun Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.autrev.2017.09.012","article-title":"Neutrophil extracellular traps (NETs) in autoimmune diseases: a comprehensive review","volume":"16","author":"Lee","year":"2017","journal-title":"Autoimmun Rev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.4049\/jimmunol.1600108","article-title":"IFN-\u03b1 negatively regulates the expression of endothelial nitric oxide synthase and nitric oxide production: implications for systemic lupus erythematosus","volume":"199","author":"Buie","year":"2017","journal-title":"J Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.cytogfr.2008.11.003","article-title":"Interferon gamma: a master regulator of atherosclerosis","volume":"20","author":"McLaren","year":"2009","journal-title":"Cytokine Growth Factor Rev."},{"key":"B33","first-page":"1789","article-title":"Novel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus","volume":"35","author":"Rho","year":"2008","journal-title":"J Rheumatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/annrheumdis-2020-218272","article-title":"Update on the diagnosis and management of systemic lupus erythematosus","volume":"80","author":"Fanouriakis","year":"2021","journal-title":"Ann Rheum Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.intimp.2019.03.010","article-title":"Therapeutic advances in the treatment of SLE","volume":"72","author":"Mohamed","year":"2019","journal-title":"Int Immunopharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1517\/14740338.2015.1073259","article-title":"Cardiovascular risk factors, burden of disease and preventive strategies in patients with systemic lupus erythematosus: a literature review","volume":"14","author":"Benvenuti","year":"2015","journal-title":"Expert Opin Drug Saf."},{"key":"B37","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.berh.2017.09.012","article-title":"Atherosclerosis in systemic lupus erythematosus","volume":"31","author":"Croca","year":"2017","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/acr.23322","article-title":"Restrictive use of oral glucocorticoids in systemic lupus erythematosus and prevention of damage without worsening long-term disease control: an observational study","volume":"70","author":"Ruiz-Arruza","year":"2018","journal-title":"Arthritis Care Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1177\/0961203317739129","article-title":"Effect of immunosuppressive therapies on survival of systemic lupus erythematosus: a propensity score analysis of a longitudinal cohort","volume":"27","author":"Mok","year":"2018","journal-title":"Lupus."},{"key":"B40","doi-asserted-by":"publisher","first-page":"102887","DOI":"10.1016\/j.autrev.2021.102887","article-title":"The impact of antimalarial agents on traditional and non-traditional subclinical atherosclerosis biomarkers in systemic lupus erythematosus: a systematic review and meta-analysis","volume":"20","author":"Mungu\u00eda-Realpozo","year":"2021","journal-title":"Autoimmun Rev."},{"key":"B41","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/0002-9343(94)90151-1","article-title":"Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis","volume":"96","author":"Petri","year":"1994","journal-title":"Am J Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1093\/rheumatology\/keu148","article-title":"Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus","volume":"53","author":"Ruiz-Arruza","year":"2014","journal-title":"Rheumatology."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3424136","DOI":"10.1155\/2018\/3424136","article-title":"Protective effects of hydroxychloroquine against accelerated atherosclerosis in systemic lupus erythematosus","volume":"2018","author":"Floris","year":"2018","journal-title":"Mediators Inflamm."},{"key":"B44","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/BOR.0000000000000527","article-title":"Glucocorticoids and antimalarials in systemic lupus erythematosus: an update and future directions","volume":"30","author":"Ugarte","year":"2018","journal-title":"Curr Opin Rheumatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3899\/jrheum.150983","article-title":"Modified Framingham risk factor score for systemic lupus erythematosus","volume":"43","author":"Urowitz","year":"2016","journal-title":"J Rheumatol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1136\/annrheumdis-2021-221733","article-title":"EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome","volume":"81","author":"Drosos","year":"2022","journal-title":"Ann Rheum Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1468-3083.2006.01838.x","article-title":"Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review","volume":"21","author":"No\u00ebl","year":"2007","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1177\/0961203312436861","article-title":"Statin-induced lupus: a case\/non-case study in a nationwide pharmacovigilance database","volume":"21","author":"Moulis","year":"2012","journal-title":"Lupus."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.3899\/jrheum.171389","article-title":"The Effect of statin use on mortality in systemic autoimmune rheumatic diseases","volume":"45","author":"Jorge","year":"2018","journal-title":"J Rheumatol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/0961203317716787","article-title":"Effects of statins on thrombosis development in patients with systemic lupus erythematosus and antiphospholipid antibodies","volume":"27","author":"Watanabe","year":"2018","journal-title":"Lupus."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1093\/eurheartj\/ehm316","article-title":"European guidelines on cardiovascular disease prevention in clinical practice: executive summary: fourth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (Constituted by representatives of nine societies and by invited experts)","volume":"28","author":"Graham","year":"2007","journal-title":"Eur Heart J."},{"key":"B52","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.autrev.2013.10.014","article-title":"Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis","volume":"13","author":"Arnaud","year":"2014","journal-title":"Autoimmun Rev."},{"key":"B53","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jtcvs.2014.11.038","article-title":"Outcomes of coronary artery bypass grafting in patients with inflammatory rheumatic diseases: an 11-year nationwide cohort study","volume":"149","author":"Lai","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1136\/annrheumdis-2015-207719","article-title":"Outcomes of percutaneous coronary intervention in patients with rheumatoid arthritis and systemic lupus erythematosus: an 11-year nationwide cohort study","volume":"75","author":"Lai","year":"2016","journal-title":"Ann Rheum Dis."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.951188\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T07:14:05Z","timestamp":1660115645000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.951188\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,10]]},"references-count":54,"alternative-id":["10.3389\/fcvm.2022.951188"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.951188","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2022,8,10]]},"article-number":"951188"}}